We examined the effect of dapoxetine, a selective serotonin-reuptake inhibitor
used in treatment of premature ejaculation in the carbon tetrachloride (CCl4)
model of acute liver injury. Dapoxetine (5.4, 10.2 or 21.4 mg/kg) was given
once daily orally simultaneously with CCl4 and for 2 consecutive days
thereafter. We measured serum aminotransferases activities, liver lipid
peroxidation (malondialdehyde: MDA), nitric oxide and reduced glutathione
(GSH) concentrations, serum MDA, nitric oxide, serum and liver paraoxonase1 (PON-1) activities and liver Na+
/K+
-ATPase activity. Hepatic histopathology
was also done. Results: Rats treated with CCl4 exhibited significantly raised
serum aspartate aminotransferase and alanine aminotransferase activities.
There were also increased MDA and nitric oxide concentrations in liver and
serum whereas liver GSH concentrations, liver and serum PON-1 activities as
well as liver Na+
/K+
-ATPase activity were depressed compared with the
vehicle group. The administration of dapoxetine to CCl4-treated rats
attenuated liver injury, as indicated by the decrease in serum liver enzymes
and markers of oxidative stress. The histopathological change induced by
CCl4 such as centrilobular necrosis, vacuolar and fatty degeneration, distorted
architecture was also improved by dapoxetine in a dose-dependent manner.
Thus, in acute liver injury caused by CCl4, the concurrent administration of
the antidepressant drug dapoxetine was associated with decreasing oxidative
stress and less extent of liver tissue damage
Keywords: dapoxetine, antidepressants, carbon tetrachloride, liver injury,
oxidative stress, paraoxonase, Na+
/K+
-ATPase